DC-HIL+ CD14+ HLA-DR no/low cells are a potential blood marker and therapeutic target for melanoma.
Turrentine J, Chung JS, Nezafati K, Tamura K, Harker-Murray A, Huth J, Sharma RR, Harker DB, Ariizumi K, Cruz PD Jr.
Turrentine J, et al. Among authors: sharma rr.
J Invest Dermatol. 2014 Nov;134(11):2839-2842. doi: 10.1038/jid.2014.248. Epub 2014 Jun 16.
J Invest Dermatol. 2014.
PMID: 24933321
Free PMC article.
No abstract available.